Ganglioside agglutination immunoassay for rapid detection of autoantibodies in immune‐mediated neuropathy

Open Access
Publisher Website
Google Scholar
Abstract
Elevated levels of serum autoantibodies directed against gangliosides are closely associated with acute and chronic autoimmune neuropathies. An agglutination immunoassay using polystyrene microparticles coated with a total extract of brain gangliosides was used to test patient sera for the presence of anti‐ganglioside antibodies. Results were compared with those obtained by ELISA for anti‐GM1 and anti‐GQ1b ganglioside antibodies. Eight of the twelve sera from patients with multifocal motor neuropathy and seven of the thirteen sera from patients with Guillain‐Barré syndrome were positive for the presence of anti‐ganglioside antibodies by the ganglioside agglutination immunoassay. The assay compared favorably with the ELISA system in sensitivity and specificity, while requiring a fraction of the time and cost to perform. The new assay can serve as a rapid and effective method for detecting or screening for anti‐ganglioside antibodies in patients with acute or chronic immune‐mediated neuropathies. It would be particularly useful for detecting antibodies that react with multiple gangliosides, or with minor or as yet uncharacterized gangliosides. J. Clin. Lab. Anal. 15:96–99, 2001. © 2001 Wiley‐Liss, Inc.